#CPHI22: Sup­ply chain woes are still bear­ing down on man­u­fac­tur­ers

It’s no se­cret that the wider events in the glob­al land­scape, such as the lin­ger­ing ef­fects of Covid-19 as well as the on­go­ing con­flict in Ukraine and in­fla­tion costs, have made man­u­fac­tur­ers feel the pinch this year. These el­e­ments have cre­at­ed chal­lenges for man­u­fac­tur­ers and man­ag­ing sup­ply chains.

Look­ing deep­er in­to the sup­ply chain is­sues, Au­re­lio Arias, the en­gage­ment man­ag­er for thought lead­er­ship at IQVIA, said in an email to End­points News that now ris­ing en­er­gy costs are the lat­est sup­ply is­sue to hit. This was brought up by Elis­a­beth Stam­pa, pres­i­dent of Med­i­cines for Eu­rope, a group that rep­re­sents the gener­ic in­dus­try on the con­ti­nent. Stam­pa had sent a let­ter ad­dressed to en­er­gy min­is­ters and com­mis­sion­ers con­cern­ing in­fla­tion and the costs of en­er­gy on the sup­ply of gener­ic med­i­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER